ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2069

Alcohol Consumption Is Not an Independent Predictor of Fatigue Severity over Time

Katie Druce1, Belay Yimer 1, Lis Cordingley 2, Mark Lunt 1, Simon Kyle 3, Will Dixon 4 and John McBeth 4, 1Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, 2Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, 3Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK, Oxford, 4Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: alcohol use, Fatigue, pain and mood

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Alcohol consumption is a common, but declining, lifestyle behaviour of UK adults. Previous research has shown that among people with rheumatoid arthritis (RA) moderate drinkers report reduced symptom severity (e.g. pain) compared to non-drinkers, leading some to argue that moderate alcohol consumption may be beneficial for the management of chronic pain conditions. Little is known whether alcohol consumption may also reduce fatigue severity despite fatigue and pain sharing a number of common risk factors and possible mechanisms. This study sought to determine whether alcohol consumption was associated with levels of fatigue severity.

Methods: 270 participants recruited to the QUAlity of life, Sleep and rheumatoid ARthritis study (QUASAR) recorded fatigue and pain severity, measured on an ordinal scale from 1 (none) to 5 (very severe), daily for 30 days using a smartphone app. Average weekly alcohol consumption (in units) was reported at baseline and categorised as none- (0), moderate- (1-15) and heavy-drinkers (16+). Participants also reported an assessment of disease activity (Routine Assessment of Patient Index Data 3; RAPID-3), number of co-morbidities and medications and mental health (Hospital Anxiety and Depression (HAD) scale). Ordinal probit models with random effects tested the independent relationship between alcohol consumption and fatigue severity over time. The model was cumulatively adjusted for disease activity, pain, medications and co-morbidities, and mental health, and marginal effects were calculated. Results are presented as percentage point change in the probability of reporting severe or very severe fatigue and 95% confidence intervals (95%CI).

Results: Of 267 participants who provided alcohol and fatigue data, 107 (40%) were non-drinkers, 139 (52%) were moderate-drinkers and 21 (8%) were heavy-drinkers. Compared to non-drinkers, moderate- and heavy-drinkers were 11 (95%CI:-0.18—0.03) and 12 (-0.22—0.01) percentage points less likely to report severe fatigue, respectively. Both groups were 1 percentage point less likely to report very severe fatigue compared to non-drinkers (-0.02—0.002; -0.02—0.001, respectively). The relationship between alcohol consumption and fatigue severity was attenuated and became non-significant upon adjustment all co-variates. Fatigue severity was predicted by concurrent pain reports, depressive mood and the number of medications, but not RAPID-3 (Table).

Conclusion: In contrast to previous research, we did not find alcohol consumption, at a moderate or heavy level, to be independently associated with fatigue severity over time. It is unlikely that moderate consumption of alcohol will be directly beneficial for those seeking to manage fatigue. Instead, greater benefits may be obtained through the use of management strategies which target pain, medication use, and mood.

Table – Marginal effects for the probability of fatigue severity reporting -95% confidence intervals- †Referent category 0 units. ‡adjusted for age, sex and day-time-. Bold denotes statistical significance


Disclosure: K. Druce, None; B. Yimer, None; L. Cordingley, None; M. Lunt, None; S. Kyle, None; W. Dixon, None; J. McBeth, None.

To cite this abstract in AMA style:

Druce K, Yimer B, Cordingley L, Lunt M, Kyle S, Dixon W, McBeth J. Alcohol Consumption Is Not an Independent Predictor of Fatigue Severity over Time [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/alcohol-consumption-is-not-an-independent-predictor-of-fatigue-severity-over-time/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/alcohol-consumption-is-not-an-independent-predictor-of-fatigue-severity-over-time/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology